FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

330440001: Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3692832010 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692834011 Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) true Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Betamethasone+neomycin sulfate (product) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Miscellaneous eye preparations (product) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Betamethasone false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Adrenal hormone false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing neomycin in topical dosage form (medicinal product form) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing betamethasone in topical dosage form (medicinal product form) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Betamethasone sodium phosphate false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Corticosterone false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Neomycin sulfate false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Skin anti-infective (substance) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Adrenal hormone agent (substance) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Glucocorticoid hormone false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Bactericide false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a pour principe actif (attribut) Local anti-infective (substance) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing betamethasone in ophthalmic dosage form (medicinal product form) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing neomycin in ophthalmic dosage form (medicinal product form) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage oculaire (forme pharmaceutique) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) a une forme pharmaceutique (attribut) pommade ophtalmique true Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) est un(e) (attribut) Product containing betamethasone and neomycin (medicinal product) false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Count of base of active ingredient deux false Inferred relationship Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value (attribute) cinq false Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator value (attribute) un false Inferred relationship Some 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has precise active ingredient Betamethasone sodium phosphate true Inferred relationship Some 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has precise active ingredient Neomycin sulfate true Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength denominator unit g true Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has basis of strength substance (attribute) Betamethasone sodium phosphate true Inferred relationship Some 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has basis of strength substance (attribute) Neomycin sulfate true Inferred relationship Some 2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) Has concentration strength denominator unit g true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start